TRP
TISSUE REP FPO [TRP]
Healthcare · ASX Small Cap
$0.0800 -11.1%
Updated 8 Sep 2026 · Signals refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scansFirst seen: 2026-04-28
Get alerts when TRP triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
- Volume surging at 30.3x normal while price falls — heavy selling pressure
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Sitting near support — this level has held before and could attract buyers again
- Drifting lower — down 9.1% over the last 5 days
- Volatility is expanding fast — choppy price action, so buckle up
- Low cash runway (3 quarters) - dilution risk
- 4C filed 2026-07-30
- Low P/S ratio (1.8x)
- Revenue in sharp decline (-20%)
- EPS estimates revised downward (-10pts)
- Near 52-week low (8% of range)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 71% over the past year
- Altman Z-Score distress zone (-1.15 < 1.81, low-confidence approx)
- Liquidity risk: 6 zero-volume days in last 20
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Deeply negative margins (-179%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -20% — the top line is shrinking
- The bigger volume days are the down days — volume-weighted momentum is negative (-4.44%/day)
Recent Catalysts
NONE TRP to resume direct distribution of TR Pro in ANZ
NONE Appendix 4G and Corporate Governance Statement
NONE Notice of General Meeting and Proxy Form
LOW Appendix 4E and Annual Report 30 June 2026
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-09-01 | TRP to resume direct distribution of TR Pro in ANZ PRICE SENSITIVE |
| 2026-08-31 | Appendix 4G and Corporate Governance Statement |
| 2026-08-31 | Appendix 4E and Annual Report 30 June 2026 PRICE SENSITIVE |
| 2026-08-16 | Notice of General Meeting and Proxy Form |
| 2026-07-30 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$5.4M
Market Cap
80K
Avg Volume
30.3x
Vol Ratio
$0.06 — $0.48
52-Week Range
N/A
Short Interest
2 qtrs
Cash Runway
-47.3%
ROE
-179.3%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 57% |
| L | Leader vs Laggard | laggard | RS: -9 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
113 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track TRP and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required